Evidence map›Paper›PMID 33498390›Full record

ArticleGenes2021

Differential DNA Methylation Landscape in Skin Fibroblasts from African Americans with Systemic Sclerosis.

DeAnna Baker Frost, Willian da Silveira, E Starr Hazard, Ilia Atanelishvili, Robert C Wilson, Jonathan Flume, Kayleigh L Day, James C Oates, Galina S Bogatkevich, Carol Feghali-Bostwick and 2 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases.Clinical reviews in allergy & immunology · 2022
    Review
  12. Novel role of long non-coding RNAs in autoimmune cutaneous disease.Journal of cell communication and signaling · 2022
    Review
  13. Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis.International journal of general medicine · 2022
    Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

DeAnna Baker FrostDepartment of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0002-9224-1391
Willian da SilveiraInstitute for Global Food Security, School of Biological Sciences, Queens University Belfast, Belfast BT9 5DL, UK.
E Starr HazardComputational Biology Resource Center, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0002-4645-7642
Ilia AtanelishviliDepartment of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
Robert C WilsonDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Jonathan FlumeDepartment of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
Kayleigh L DayStevenson University, Stevenson, MD 21117, USA.
James C OatesDepartment of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
Galina S BogatkevichDepartment of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
Carol Feghali-BostwickDepartment of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0002-6750-6407
Gary HardimanInstitute for Global Food Security, School of Biological Sciences, Queens University Belfast, Belfast BT9 5DL, UK.ORCID 0000-0003-4558-0400
Paula S RamosDepartment of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0002-9433-6634
Medical University of South Carolina · USQueen's University Belfast · GBStevenson University · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J Lemasters · 2009 to 2026
$42.7M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Garth R Swanson · 2020 to 2026
$8.8M
Resource CoreP30AR072582 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JAMES C OATES · 2017 to 2026
$8.5M
Sociobiological Responses to Stress in Prostate Cancer SurvivorsU54MD010706 · NIMHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LENERT, LESLIE A. · 2016 to 2020
$8.0M
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent ModelU01DA045300 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Christine Cheng, Dongjun Chung · 2018 to 2026
$6.1M
South Carolina Clinical & Translational Research Institute (SCTR)KL2TR001452 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MCRAE-CLARK, AIMEE L · 2015 to 2024
$5.9M
Patient Resource CoreP60AR062755 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GILKESON, GARY S · 2012 to 2016
$5.8M
Scleroderma Twin Study and analysis of Estrogen in patients with dcSScK24AR060297 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FEGHALI-BOSTWICK, CAROL A. · 2013 to 2025
$1.4M
The role of natural selection in SLE risk among African-AmericansK01AR067280 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAMOS, PAULA SOFIA · 2015 to 2018
$516k
DNA methylation biomarkers of scleroderma-associated interstitial lung diseaseR03AR065801 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAMOS, PAULA SOFIA · 2014 to 2016
$231k
NCATS NIH HHS KL2 TR001452NCATS NIH HHS UL1 TR001450NCI NIH HHS P30 CA138313NIAMS NIH HHS K01 AR067280NIAMS NIH HHS K24 AR060297NIAMS NIH HHS P30 AR072582NIAMS NIH HHS P60 AR062755NIAMS NIH HHS R03 AR065801NIDA NIH HHS DA045300, MD010706NIDA NIH HHS U01 DA045300NIDDK NIH HHS P30 DK123704NIMHD NIH HHS U54 MD010706
6 · The paper itself

Abstract

The etiology and reasons underlying the ethnic disparities in systemic sclerosis (SSc) remain unknown. African Americans are disproportionally affected by SSc and yet are underrepresented in research. The aim of this study was to comprehensively investigate the association of DNA methylation levels with SSc in dermal fibroblasts from patients of African ancestry. Reduced representation bisulfite sequencing (RRBS) was performed on primary dermal fibroblasts from 15 SSc patients and 15 controls of African ancestry, and over 3.8 million CpG sites were tested for differential methylation patterns between cases and controls. The dermal fibroblasts from African American patients exhibited widespread reduced DNA methylation. Differentially methylated CpG sites were most enriched in introns and intergenic regions while depleted in 5' UTR, promoters, and CpG islands. Seventeen genes and eleven promoters showed significant differential methylation, mostly in non-coding RNA genes and pseudogenes. Gene set enrichment analysis (GSEA) and gene ontology (GO) analyses revealed an enrichment of pathways related to interferon signaling and mesenchymal differentiation. The hypomethylation of

Indexed as

DNA MethylationEpigenesis, GeneticBlack or African AmericanComputational BiologyCpG IslandsFibroblastsGene Expression ProfilingGene OntologyGenetic Association StudiesGenetic Predisposition to DiseaseHumansPromoter Regions, GeneticScleroderma, SystemicAfrican AmericanDNA methylationgenomeskin fibroblastssystemic sclerosis

Identifiers

PMID33498390
PMCPMC7909410
OpenAlexW3124466037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.